Oxular
Oxford
About Oxular
Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $76.7M
- Funding stage: M&A
- Last round: Series B (Mar 2021)
- Website: oxular.com
- Phone: +44 (0)1865 636200
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oxular-24671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.